Clinical Decision Biological Biomarker and Prognosis Prediction of Hepatocellular Carcinoma by Deep Learning

Clinical trial NCT05257694 · UNKNOWN

Trial details

NCT number: NCT05257694
Sponsor: Ping Liang
Status: UNKNOWN
Study type: OBSERVATIONAL

Hepatocellular Carcinoma Contrast-enhanced Ultrasound Prognosis Surgery Ablation

Start date: 2022-01-01
Primary completion: 2025-12-31
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.